Why is Gufic BioScience falling/rising?

As of 25-Sep, Gufic BioSciences Ltd is experiencing a decline in its stock price, currently at Rs 362.30, reflecting a decrease of Rs 5.35 or 1.46%. The stock has underperformed its sector by 0.6% today and has been on a downward trend, falling consecutively for the last two days with a total decline of 2.54%. It has also touched an intraday low of Rs 359.85. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 35.52% compared to the 5-day average. Despite the company's high management efficiency and strong ability to service debt, it has reported negative results for the last three consecutive quarters, with a notable decline in profit after tax and a high valuation compared to its earnings.
In the broader market context, Gufic BioSciences has shown a slight decline of 0.11% over the past week, while the benchmark Sensex has decreased by 2.23%, indicating that the stock has outperformed the market in this timeframe. However, over the past month, Gufic has fallen by 4.28%, contrasting with the Sensex's smaller decline of 0.58%. Year-to-date, the stock has significantly underperformed, with a drop of 20.03% compared to the Sensex's gain of 3.87%. This underperformance is compounded by the company's recent financial struggles, which have led to a negative sentiment among investors, further contributing to the stock's decline.